- Home
- KRYS vs SMTC Comparison
KRYS vs SMTC Comparison
Compare KRYS & SMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- SMTC
- Stock Information
- Founded
- KRYS 2015
- SMTC 1960
- Country
- KRYS United States
- SMTC United States
- Employees
- KRYS N/A
- SMTC N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- SMTC Semiconductors
- Sector
- KRYS Health Care
- SMTC Technology
- Exchange
- KRYS Nasdaq
- SMTC Nasdaq
- Market Cap
- KRYS 3.8B
- SMTC 3.2B
- IPO Year
- KRYS 2017
- SMTC N/A
- Fundamental
- Price
- KRYS $143.08
- SMTC $44.57
- Analyst Decision
- KRYS Strong Buy
- SMTC Strong Buy
- Analyst Count
- KRYS 9
- SMTC 12
- Target Price
- KRYS $208.78
- SMTC $60.08
- AVG Volume (30 Days)
- KRYS 374.0K
- SMTC 2.0M
- Earning Date
- KRYS 08-04-2025
- SMTC 08-26-2025
- Dividend Yield
- KRYS N/A
- SMTC N/A
- EPS Growth
- KRYS 109.01
- SMTC N/A
- EPS
- KRYS 4.16
- SMTC N/A
- Revenue
- KRYS $333,448,000.00
- SMTC $954,242,000.00
- Revenue This Year
- KRYS $44.05
- SMTC $15.81
- Revenue Next Year
- KRYS $46.15
- SMTC $9.21
- P/E Ratio
- KRYS $34.43
- SMTC N/A
- Revenue Growth
- KRYS 247.53
- SMTC 13.83
- 52 Week Low
- KRYS $122.80
- SMTC $24.05
- 52 Week High
- KRYS $219.34
- SMTC $79.52
- Technical
- Relative Strength Index (RSI)
- KRYS 57.50
- SMTC 61.83
- Support Level
- KRYS $135.86
- SMTC $42.38
- Resistance Level
- KRYS $143.44
- SMTC $45.98
- Average True Range (ATR)
- KRYS 5.15
- SMTC 1.72
- MACD
- KRYS 1.07
- SMTC 0.03
- Stochastic Oscillator
- KRYS 80.33
- SMTC 79.09
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About SMTC Semtech Corporation
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.